XTX Topco Ltd Purchases 19,163 Shares of Privia Health Group, Inc. (NASDAQ:PRVA)

Key Points

• XTX Topco Ltd increased its stake in Privia Health Group by 57.5%, now holding 52,466 shares valued at approximately $1.18 million.
• Several hedge funds have also increased their positions, with Van Berkom & Associates Inc. purchasing nearly $45.21 million worth of shares in the first quarter.
• Wall Street analysts maintain a positive outlook, with a consensus rating of "Buy" and an average target price of $28.38 for Privia Health Group shares.

XTX Topco Ltd boosted its position in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 57.5% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 52,466 shares of the company's stock after purchasing an additional 19,163 shares during the quarter. XTX Topco Ltd's holdings in Privia Health Group were worth $1,178,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently added to or reduced their stakes in the company. CWM LLC grew its stake in shares of Privia Health Group by 50.3% during the first quarter. CWM LLC now owns 1,804 shares of the company's stock valued at $40,000 after acquiring an additional 604 shares in the last quarter. Bessemer Group Inc. lifted its holdings in Privia Health Group by 2,393.4% in the first quarter. Bessemer Group Inc. now owns 2,269 shares of the company's stock worth $51,000 after purchasing an additional 2,178 shares during the period. GAMMA Investing LLC lifted its holdings in Privia Health Group by 113.1% in the first quarter. GAMMA Investing LLC now owns 2,866 shares of the company's stock worth $64,000 after purchasing an additional 1,521 shares during the period. Financial Management Professionals Inc. lifted its holdings in Privia Health Group by 28.7% in the first quarter. Financial Management Professionals Inc. now owns 3,383 shares of the company's stock worth $76,000 after purchasing an additional 754 shares during the period. Finally, Quadrant Capital Group LLC lifted its holdings in Privia Health Group by 11.8% in the fourth quarter. Quadrant Capital Group LLC now owns 4,855 shares of the company's stock worth $95,000 after purchasing an additional 511 shares during the period. Institutional investors and hedge funds own 94.48% of the company's stock.

Insider Transactions at Privia Health Group

In other Privia Health Group news, CFO David Mountcastle sold 3,322 shares of the company's stock in a transaction dated Monday, May 12th. The shares were sold at an average price of $24.99, for a total transaction of $83,016.78. Following the completion of the sale, the chief financial officer directly owned 172,909 shares in the company, valued at $4,320,995.91. This represents a 1.89% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Parth Mehrotra sold 13,773 shares of the business's stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $24.99, for a total transaction of $344,187.27. Following the transaction, the chief executive officer owned 423,143 shares in the company, valued at approximately $10,574,343.57. The trade was a 3.15% decrease in their position. The disclosure for this sale can be found here. 10.70% of the stock is owned by corporate insiders.

Privia Health Group Trading Up 1.5%

NASDAQ PRVA traded up $0.28 on Wednesday, reaching $19.73. The stock had a trading volume of 1,166,952 shares, compared to its average volume of 820,984. Privia Health Group, Inc. has a 1 year low of $16.47 and a 1 year high of $26.09. The business has a 50 day moving average price of $21.47 and a 200 day moving average price of $22.88. The company has a market capitalization of $2.41 billion, a price-to-earnings ratio of 164.46, a P/E/G ratio of 3.12 and a beta of 0.80.

Wall Street Analysts Forecast Growth

PRVA has been the subject of several research analyst reports. Robert W. Baird upped their price objective on shares of Privia Health Group from $24.00 to $26.00 and gave the stock an "outperform" rating in a report on Tuesday, April 15th. JPMorgan Chase & Co. lifted their target price on Privia Health Group from $29.00 to $32.00 and gave the stock an "overweight" rating in a report on Wednesday, May 28th. Truist Financial boosted their price objective on Privia Health Group from $27.00 to $28.00 and gave the stock a "buy" rating in a report on Thursday, April 10th. Barclays boosted their price objective on Privia Health Group from $23.00 to $24.00 and gave the stock an "equal weight" rating in a report on Tuesday, May 27th. Finally, Evercore ISI cut their price objective on Privia Health Group from $30.00 to $28.00 and set an "outperform" rating on the stock in a report on Wednesday, July 9th. One research analyst has rated the stock with a hold rating, eleven have issued a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Buy" and an average target price of $28.38.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.